Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ergobilt (ERGB) - Ergonomic Chairs -- Ignore unavailable to you. Want to Upgrade?

To: Mama Bear who wrote (695)	2/23/1998 11:59:00 PM
From: Scott D. Hakala	Read Replies (2) \| Respond to of 900

Sorry Barb, But Asensio bailed out early on this one when he realized he was wrong. The subject Company has real sales, real products and real earnings. That means that it has value and can fight back, unlike Asensio's usual targets. Asensio sold out in early October and left other shorts to fight it out. He reportedly knows he was wrong on a number of points on ERGB and has kept to the sidelines. A couple of law firms confirmed looking at class actions against Asensio and others for trading on material non-public information, for posting false information, for misrepresenting the facts and for stock manipulation involving ERGB. Pretty serious stuff. Also, ERGB has been quietly reviewing its options, monitoring the activities and waiting to get into the next fiscal year when some of its product lines and recent acquisitions will have time to produce additional sales and earnings. By next fall we ought to know who was really right on this one.